Display options
Cite
Vendrell M, Muñoz G, de Gracia J. Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. Open Respir Med J. 2015;9:30-6doi: 10.2174/1874306401509010030.
Vendrell, M., Muñoz, G., & de Gracia, J. (2015). Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. The open respiratory medicine journal, 930-6. https://doi.org/10.2174/1874306401509010030
Vendrell, Montserrat, et al. "Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis." The open respiratory medicine journal vol. 9 (2015): 30-6. doi: https://doi.org/10.2174/1874306401509010030
Vendrell M, Muñoz G, de Gracia J. Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. Open Respir Med J. 2015 Mar 31;9:30-6. doi: 10.2174/1874306401509010030. eCollection 2015. PMID: 25893022; PMCID: PMC4397829.
Copy Download .nbib Format: NLM
Share it on

Open Respir Med J. 2015 Mar 31;9:30-6. doi: 10.2174/1874306401509010030. eCollection 2015.

Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis.

The open respiratory medicine journal

Montserrat Vendrell, Gerard Muñoz, Javier de Gracia

Affiliations

  1. Bronchiectasis Group. [Girona Biomedical Research Institute] IDIBGI, Dr Trueta University Hospital, Girona, Spain ; CIBER de Enfermedades Respiratorias (Ciberes CB06/06/0030), Instituto de Salud Carlos III, Spain.
  2. Bronchiectasis Group. [Girona Biomedical Research Institute] IDIBGI, Dr Trueta University Hospital, Girona, Spain.
  3. CIBER de Enfermedades Respiratorias (Ciberes CB06/06/0030), Instituto de Salud Carlos III, Spain ; Department of Pulmonology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona.

PMID: 25893022 PMCID: PMC4397829 DOI: 10.2174/1874306401509010030

Abstract

There is currently less experience with inhaled tobramycin in non-cystic fibrosis bronchiectasis than in cystic fibrosis (CF). Intravenous formulation and solution for inhalation (TSI) have been studied in non-CF bronchiectasis patients with chronic P. aeruginosa bronchial infection. An improvement in clinical parameters and a reduction in bacterial density have been shown with both inhaled solutions in these patients. However, further trials are needed to determine the most effective dose and administration protocol in these patients. Based on the current evidence, recommendations cannot be made regarding the use of TSI to treat exacerbations. Although no systemic toxicity has been reported in studies specifically investigating this treatment, patients with known kidney disease or ear disorders should be treated with caution. Adverse respiratory effects are reported to be more common in non-CF patients than in CF patients, who tend to be non-smokers and younger. Research is being conducted into the possibility of combining tobramycin with other antibiotics to increase its antibacterial activity. In this review we will present and discuss the published evidence regarding the use of inhaled tobramycin in non-CF bronchiectasis.

Keywords: Bronchiectasis; inhaled; tobramycin

References

  1. Chest. 2006 Jan;129(1 Suppl):122S-131S - PubMed
  2. Thorax. 2005 Mar;60(3):239-43 - PubMed
  3. Mol Immunol. 2013 Aug;55(1):27-34 - PubMed
  4. Antimicrob Agents Chemother. 2010 Oct;54(10):4409-15 - PubMed
  5. J Cyst Fibros. 2011 Jan;10 (1):9-14 - PubMed
  6. Thorax. 2013 Sep;68(9):812-7 - PubMed
  7. Clin Microbiol Infect. 2011 Nov;17 Suppl 6:E1-59 - PubMed
  8. J Heart Lung Transplant. 2005 Jul;24(7):932-5 - PubMed
  9. J Cyst Fibros. 2014 Dec;13(6):653-60 - PubMed
  10. J Aerosol Med. 2000 Summer;13(2):147-53 - PubMed
  11. Am J Respir Crit Care Med. 2014 Apr 15;189(8):975-82 - PubMed
  12. Am J Respir Crit Care Med. 2012 Jan 15;185(2):171-8 - PubMed
  13. Am J Respir Crit Care Med. 2012 Oct 1;186(7):657-65 - PubMed
  14. J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(4):299-305 - PubMed
  15. Chest. 2005 Apr;127(4):1420-6 - PubMed
  16. Pediatr Pulmonol. 2002 Nov;34(5):375-7 - PubMed
  17. Thorax. 2010 Jul;65 Suppl 1:i1-58 - PubMed
  18. Eur Respir J. 2014 May;43(5):1357-67 - PubMed
  19. Paediatr Drugs. 2007;9 Suppl 1:3-9 - PubMed
  20. Pulm Pharmacol Ther. 2009 Dec;22(6):526-32 - PubMed
  21. Eur Respir J. 2002 Sep;20(3):658-64 - PubMed
  22. Eur Respir J. 1997 Aug;10 (8):1754-60 - PubMed
  23. Chest. 2002 Sep;122(3):930-4 - PubMed
  24. Chest. 2007 Nov;132(5):1565-72 - PubMed
  25. J Cyst Fibros. 2004 Jun;3(2):67-91 - PubMed
  26. Pediatr Pulmonol. 2014 Nov;49(11):1076-89 - PubMed
  27. Am J Respir Crit Care Med. 2011 Feb 15;183(4):491-9 - PubMed
  28. Curr Opin Investig Drugs. 2001 Jun;2(6):755-65 - PubMed
  29. Curr Opin Pulm Med. 2008 Nov;14(6):595-9 - PubMed
  30. Chest. 2006 Nov;130(5):1503-10 - PubMed
  31. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):481-5 - PubMed
  32. Arch Bronconeumol. 2008 Nov;44(11):629-40 - PubMed
  33. Respir Med. 2013 Apr;107(4):524-33 - PubMed
  34. Lancet. 2012 Aug 18;380(9842):660-7 - PubMed
  35. N Engl J Med. 1999 Jan 7;340(1):23-30 - PubMed
  36. Pediatr Infect Dis. 1983 May-Jun;2(3):209-11 - PubMed
  37. Clin Nephrol. 2006 Dec;66(6):464-7 - PubMed
  38. Antimicrob Agents Chemother. 2005 Aug;49(8):3382-6 - PubMed
  39. Lancet. 1983 Jun 11;1(8337):1325 - PubMed
  40. J Cyst Fibros. 2013 Mar;12(2):130-40 - PubMed
  41. Br J Dis Chest. 1987 Oct;81(4):356-60 - PubMed
  42. J Cyst Fibros. 2011 Jan;10(1):54-61 - PubMed
  43. Ann Pharmacother. 2005 Jan;39(1):39-44 - PubMed
  44. Eur Respir J. 2013 May;41(5):1107-15 - PubMed
  45. Eur Respir J. 2005 Dec;26(6):1138-80 - PubMed
  46. Pharmacotherapy. 2010 Jun;30(6):562-84 - PubMed
  47. J Infect Dis. 2010 Nov 15;202(10):1585-92 - PubMed
  48. Pediatr Pulmonol. 1989;7(1):42-8 - PubMed
  49. Drugs. 2003;63(22):2501-20 - PubMed
  50. Respir Med. 1999 Jul;93(7):476-80 - PubMed
  51. J Clin Microbiol. 2005 Sep;43(9):4480-5 - PubMed
  52. J Antimicrob Chemother. 2009 Oct;64(4):829-36 - PubMed
  53. Proc Staff Meet Mayo Clin. 1946 Feb 6;21:53 - PubMed
  54. Eur Respir J. 2006 Nov;28(5):974-9 - PubMed
  55. Clin Microbiol Infect. 2005 Sep;11(9):690-703 - PubMed
  56. Am J Respir Crit Care Med. 2014 Mar 1;189(5):576-85 - PubMed

Publication Types